OBI Pharma, Inc. (TPEX:4174)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
26.25
-0.50 (-1.87%)
At close: Dec 5, 2025

OBI Pharma Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-2,361-2,310-1,046-1,614-1,531-1,378
Upgrade
Depreciation & Amortization
226.16216.82244.86240.92208.75214.53
Upgrade
Other Amortization
7.125.444.15.697.5217.31
Upgrade
Loss (Gain) From Sale of Assets
0.24-43.320.39-0.0115.08-
Upgrade
Asset Writedown & Restructuring Costs
--5.96---
Upgrade
Loss (Gain) From Sale of Investments
0.23-0.26-879.321.02-0.37-54
Upgrade
Loss (Gain) on Equity Investments
202.45233.18163.58---
Upgrade
Stock-Based Compensation
41.2563.98119.214954.0276.82
Upgrade
Other Operating Activities
-179.89-174.44-201.73-310.03-195.51-98.03
Upgrade
Change in Accounts Receivable
-2.632.28-4.441.43-2.010.07
Upgrade
Change in Inventory
-1.56-1.79-3.96-9.74-2.2-3.16
Upgrade
Change in Accounts Payable
0.692.13-0.370.620.37-0.02
Upgrade
Change in Unearned Revenue
0.441.53.133.16--77.64
Upgrade
Change in Other Net Operating Assets
120.43171.01-57.89-87.84-1.5720.75
Upgrade
Operating Cash Flow
-1,943-1,834-1,653-1,620-1,064-1,609
Upgrade
Capital Expenditures
-43.94-113.24-101.93-254.65-241.33-182.68
Upgrade
Sale of Property, Plant & Equipment
0.14144.630.20.05--
Upgrade
Cash Acquisitions
----472.65-
Upgrade
Divestitures
--30.41-564.08---
Upgrade
Sale (Purchase) of Intangibles
-6.75-6.32-6.23-45.91-3.86-2.96
Upgrade
Investment in Securities
40.3481.13-2,110109.29-140-
Upgrade
Other Investing Activities
-11.247.23-13.1721.33-4.79-10.26
Upgrade
Investing Cash Flow
-21.5483.02-2,795-169.8982.68-195.9
Upgrade
Short-Term Debt Issued
-0.41-15.71-9.47
Upgrade
Long-Term Debt Issued
-100----
Upgrade
Total Debt Issued
146.2100.41-15.71-9.47
Upgrade
Short-Term Debt Repaid
--4.31-11.4--9.47-
Upgrade
Long-Term Debt Repaid
--84.44-51.61-59.31-58.07-54.6
Upgrade
Total Debt Repaid
-134.51-88.74-63.01-59.31-67.54-54.6
Upgrade
Net Debt Issued (Repaid)
11.6911.67-63.01-43.61-67.54-45.13
Upgrade
Issuance of Common Stock
2,1632,16317.613,15016.9922.94
Upgrade
Other Financing Activities
18.63-0652.47903.59214.3305.29
Upgrade
Financing Cash Flow
2,1942,175607.074,010163.75283.09
Upgrade
Foreign Exchange Rate Adjustments
-6.348.4-0.568.53-8.060.54
Upgrade
Net Cash Flow
222.75832.77-3,8422,229-826.12-1,522
Upgrade
Free Cash Flow
-1,987-1,947-1,755-1,874-1,306-1,792
Upgrade
Free Cash Flow Margin
-4031.85%-3105.95%-4223.71%-39786.71%-6956.13%-1272.04%
Upgrade
Free Cash Flow Per Share
-7.68-8.33-7.66-8.44-6.56-9.02
Upgrade
Cash Interest Paid
12.7514.653.743.993.84.18
Upgrade
Cash Income Tax Paid
--12.38-7.28-9.56-15.154.39
Upgrade
Levered Free Cash Flow
-1,168-1,028-1,228-1,406-1,002-770.41
Upgrade
Unlevered Free Cash Flow
-1,160-1,021-1,223-1,403-999.39-767.8
Upgrade
Change in Working Capital
117.36175.12-63.54-92.37376.71-388.14
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.